Glenview Capital Management
ELAN icon

Glenview Capital Management’s Elanco Animal Health ELAN Stock Holding History

Glenview Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,618,232
Closed -$77.1M – 48
2019
Q4 		$77.1M Buy
+2,618,232
New +$71.1M 0.67% 35

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Amundi Asset Management US
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenview Capital Management's ELAN Position: Q1 2020 in Review

Glenview Capital Management sold out of Elanco Animal Health (ELAN) in Q1 2020, closing a stake of 2,618,232 shares — an estimated $77.1M sold.

Glenview Capital Management first reported a position in ELAN in Q4 2019 and held it in 1 quarter. The position peaked at $77.1M in Q4 2019. 372 funds tracked by Wall St. Rank hold ELAN as of Q1 2020.

  • Glenview Capital Management reported no remaining Elanco Animal Health position as of Q1 2020 after selling out during the quarter.
  • Glenview Capital Management sold 2,618,232 Elanco Animal Health shares in Q1 2020, an estimated $77.1M.
  • Glenview Capital Management first reported a position in Elanco Animal Health in Q4 2019 and held it in 1 quarter.
  • Glenview Capital Management's Elanco Animal Health position peaked at $77.1M in Q4 2019.
  • 372 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2020.

Based on Glenview Capital Management's 13F filing for Q1 2020, filed 15 May 2020.